Samuel O. Freedman

Samuel Orkin Freedman ( born May 8, 1928 in Montreal ) is a Canadian immunologist.

Life

Freedman earned a bachelor's degree in 1948 and 1958, an MD as graduating from medical school, both from McGill University. His training as a specialist in immunology, he completed at Roosevelt Hospital in New York City and at the Montreal General Hospital. In 1963 he received a professorship at McGill University, 1969, he was research director of the newly founded Lady Davis Institute at the Jewish General Hospital, a teaching hospital of the McGill University.

From 1977 to 1981 Freedman was dean of the medical faculty. In 1981 he assumed the position of vice principal (similar to that of a vice-rector ) for academic affairs. In 1991 he became head of the Lady Davis Institute, where he focused the research on the following areas: AIDS and infectious diseases, aging, molecular oncology, pharmacology of the perinatal period, Experimental Medicine, Epidemiology and Health Sciences. In 2000 he became Professor Emeritus at McGill University, but remained until 2008 advisory at Jewish General Hospital operates.

Freedman is married and has four children, three sons and a daughter. His eldest son, David O. Freedman is a professor of internal medicine and epidemiology at the University of Alabama at Birmingham.

Work

Together with Phil discovered gold Freedman, 1965, the carcinoembryonic antigen ( CEA) and could explain its biological and clinical significance. CEA is now used as a tumor marker for colorectal cancer and other malignant tumors.

During his tenure as dean of the medical faculty of McGill University, the Faculty has grown into one of the leading medical research institutions. During his time as vice - principal, he was responsible for the establishment of medical research institutions in the teaching hospitals of the University: Jewish General Hospital, Royal Victoria Hospital, Montreal Children 's Hospital.

Freedman was one of the editors at the following scientific journals: The Journal of Clinical Immunology and Allergy, Investigative and Cell Pathology, Clinical and Investigative Medicine and In Vivo.

Awards (selection)

704748
de